← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review article (169)Early study (phase 1 or 2) (25)Description of some patients (97)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2005)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir (2023-02-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory (2023-02-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study (2023-02-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients (2023-01-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B (2023-01-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. (2022/12/31) ♡
• Prevalence of hepatitis B and C virus infections in Lao People's Democratic Republic: The first national population-based cross-sectional survey. (2022/12/30) ♡
• H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment. (2022/12/30) ♡
• Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. (2022/12/29) ♡
• Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern Australia. (2022/12/28) ♡
• Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. (2022/12/26) ♡
• An ultra-long-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. (2022/12/23) ♡
• ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells. (2022/12/23) ♡
• Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon. (2022/12/23) ♡
• The Impact of B/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis. (2022/12/22) ♡
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis. (2022/12/20) ♡
• [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)]. (2022/12/20) ♡
• [Efficacy and safety of inactivated novel coronavirus vaccine inoculation in patients with chronic hepatitis B]. (2022/12/20) ♡
• Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B. (2022/12/19) ♡
• Effect of nucleos (t) ide analogs on blood lipid profiles in patients with chronic hepatitis B: A cross-sectional survey. (2022/12/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Can G-quadruplex become a promising target in HBV therapy? (2022/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prospects for NK-based immunotherapy of chronic HBV infection. (2022/12/15) ♡
• The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis. (2022/12/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Correlation between COVID-19 and hepatitis B: A systematic review. (2022/12/14) ♡
• Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease. (2022/12/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications. (2022/12/13) ♡
• Hepatitis B Therapeutic Vaccine: A Patent Review. (2022/12/12) ♡
• The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases. (2022/12/12) ♡
• pgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation. (2022/12/12) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Influence of Vitamin A supplementation on inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials. (2022/12/10) ♡
• Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target. (2022/12/09) ♡
• Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C. (2022/12/07) ♡
• Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population. (2022/12/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HebernaSvac) for the Treatment of Chronic Hepatitis B. (2022/12/07) ♡
• Identification of antibodies cross-reactive with woodchuck immune cells and activation of virus-specific and global cytotoxic T cell responses by anti-PD-1 and anti-PD-L1 in experimental chronic hepatitis B and persistent occult hepadnaviral infection. (2022/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Systematic Review on Current Trends in the Treatment of Chronic Hepatitis B to Predict Disease Remission and Relapse. (2022/12/06) ♡
• Evulation of prolidase enzyme, and galectin levels as a marker for fibrosis in patients with chronic hepatitis B. (2022/12/01) ♡
• [Comparison of therapeutic efficacy of Wuling Capsules prepared with different methods for rats with syndrome of liver Qi stagnation, spleen deficiency, and blood stasis]. (2022/12/01) ♡
• Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022/12/01) ♡
• Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Various Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA). (2022/11/29) ♡
• HBCrag Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. (2022/11/29) ♡
• Noncompliance with Therapeutic Guidelines for Chronic Hepatitis B Patients in Minas Gerais, Brazil. (2022/11/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gene Editing Technologies to Target HBV cccDNA. (2022/11/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case Report of Diffuse Alveolar Hemorrhage Coexisting With Immunoglobulin A (IgA) Nephropathy. (2022/11/27) ♡
• Use of Golgi protein 73 serum for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community. (2022/11/20) ♡
• High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy. (2022/11/20) ♡
• [Considerations on expanding the indications for antiviral therapy from the perspective of staging of chronic hepatitis B virus infection]. (2022/11/20) ♡
• [Expanding antiviral therapy for chronic hepatitis B: scale up screening and treatment]. (2022/11/20) ♡
• [The study of a key molecule Caspase-1 of inflammasome in hepatitis B virus-related diseases]. (2022/11/20) ♡
• [Clinical significance of ultrasound combined with serological indexes for predicting nonalcoholic fatty liver disease in patients with chronic hepatitis B with normal or slightly elevated alanine aminotransferase]. (2022/11/20) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.